ARDS (OTC)
ARIDIS PHARMACEUTICAL INC
$0.000200
-0.002600 (-92.86%)
Prev close: $0.002800
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Vu L. Truong
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $0.01M
- Employees
- 37
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2023 (Q3)
|
$0.00 | $-0.10 | +0.1020 | +100.00% |
|
Dec 2022 (Q4)
|
$-0.60 | $-0.42 | -0.1818 | -43.47% |
|
Sep 2022 (Q3)
|
$-0.47 | $-0.17 | -0.2966 | -171.05% |
|
Jun 2022 (Q2)
|
$-0.45 | $-0.06 | -0.3888 | -635.29% |
Financial Statements
| Revenues | $22.36M |
| Benefits Costs and Expenses | $33.08M |
| Costs And Expenses | $23.24M |
| Operating Expenses | $23.24M |
| Depreciation and Amortization | $304.00K |
| Research and Development | $17.38M |
| Other Operating Expenses | $5.56M |
| Operating Income/Loss | -$883.00K |
| Income/Loss From Continuing Operations After Tax | -$1.14M |
| Income/Loss From Continuing Operations Before Tax | -$10.73M |
| Net Income/Loss | -$1.14M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$1.14M |
| Net Income/Loss Available To Common Stockholders, Basic | -$1.14M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.11 |
| Basic Average Shares | 71,766,527 |
| Assets | $6.53M |
| Current Assets | $4.11M |
| Noncurrent Assets | $2.42M |
| Fixed Assets | $511.00K |
| Other Non-current Assets | $1.91M |
| Liabilities | $18.34M |
| Current Liabilities | $17.48M |
| Accounts Payable | $5.41M |
| Wages | $435.00K |
| Other Current Liabilities | $11.64M |
| Noncurrent Liabilities | $854.00K |
| Equity | -$11.80M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$11.80M |
| Liabilities And Equity | $6.53M |
| Net Cash Flow From Operating Activities | -$17.89M |
| Net Cash Flow From Operating Activities, Continuing | -$17.89M |
| Net Cash Flow From Investing Activities | -$35.00K |
| Net Cash Flow From Investing Activities, Continuing | -$35.00K |
| Net Cash Flow From Financing Activities | $15.32M |
| Net Cash Flow From Financing Activities, Continuing | $15.32M |
| Net Cash Flow | -$2.60M |
| Net Cash Flow, Continuing | -$2.60M |
| Comprehensive Income/Loss | $6.65M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $6.65M |
| Other Comprehensive Income/Loss | $6.65M |